Clinical Trials on C. Difficile Enteritis in United Kingdom

Total 1437 results

Vedanta Biosciences, Inc.

Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303)

Clostridium Difficile Infection Recurrence | Recurrent Clostridium Difficile Infection | Clostridium Difficile | Diarrhea Infectious | CDI | Clostridium Difficile Infections | Clostridioides Difficile Infection | C.Difficile Diarrhea | Clostridioides Difficile Infection Recurrence | C. Diff Infection

United States
University of Wisconsin, Madison
Mayo Clinic; Medical College of Wisconsin; Agency for Healthcare Research and... and other collaborators

Completed

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | CDI | C.Difficile Diarrhea | C. Diff Colitis | C.Difficile Colitis

United States
Brigham and Women's Hospital
Centers for Disease Control and Prevention; Harvard Pilgrim Health Care Institute and other collaborators

Recruiting

Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile

C. Difficile

United States
State University of New York at Buffalo

Withdrawn

Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy (c diff)

C. Difficile Infection

United States
Providence Holy Cross Medical Center

Unknown

Reduction of C-Difficile Infection Using Stool Transplant (FMT)

C-difficile

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects

Bacterial Enteritis

United Kingdom
Deinove

Recruiting

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Clostridium Difficile (C. Difficile)

United States, Canada
The University of Texas Health Science Center,...
Kelsey Research Foundation; Roderick MacDonald Research Fund at Baylor St.... and other collaborators

Completed

Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route

C. Difficile

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Enrolling by invitation

FQ Restriction for the Prevention of CDI (FIRST)

Clostridium Difficile Infection | Clostridium Difficile | C Difficile Colitis

United States
University College London Hospitals

Unknown

Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.

Radiation Enteritis | Radiation Proctitis

United Kingdom
Memorial Sloan Kettering Cancer Center

Completed

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Cancer | C. Difficile Infection

United States
The University of Texas Health Science Center,...

Terminated

Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)

Recurrent C. Difficile Infection

United States
The University of Texas Health Science Center,...

Completed

Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea

Recurrent C. Difficile Associated Diarrhea

United States
Duke University

Completed

Impact of Oral Antibiotic Treatment on C. Difficile (C-Diff)

Diarrhea | Enterocolitis | C. Difficile

United States
Northampton General Hospital NHS Trust

Completed

Study Assessing the Position of Cricothyroid Membrane in Relation to Movement of Neck From Neutral to Extended Position (ULOC)

Difficult Intubation

United Kingdom
Finch Research and Development LLC.

Terminated

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (PRISM4)

Recurrent C. Difficile Infection

United States, Canada
NHS Tayside

Completed

Videolaryngoscopy in Patients With Cervical Spine Immobilisation

Intubation; Difficult

United Kingdom
Baylor College of Medicine
Michael E. DeBakey VA Medical Center

Enrolling by invitation

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Active C. Difficile Colitis

United States
University of Liverpool

Completed

An Exploration of Antenatal Hand Expression.

Feeding; Difficult, Newborn

United Kingdom
Oxford University Hospitals NHS Trust

Withdrawn

Feasibility of Using Depth-of-sedation Measuring Equipment (BIS) to Guide Awake Fibreoptic Intubation

Known Difficult Intubation

United Kingdom
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Completed

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation (GRAFT)

Clostridium Difficile Infection | CDI | C.Difficile Diarrhea

United States
University Hospitals Coventry and Warwickshire...
Oxford University Hospitals NHS Trust

Completed

Patient Experience Following Awake Fibreoptic Intubation Compared to Asleep Fibreoptic Intubation

Intubation;Difficult | Tracheal Intubation

United Kingdom
University College, London
Schering-Plough

Completed

The Role of Dendritic Cells in Hepatitis C Infection

Chronic Hepatitis C Infection

United Kingdom
Synthetic Biologics Inc.
Spaulding Clinical Research LLC

Completed

Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020

Enteritis Caused by Radiation

United States
Synthetic Biologics Inc.
Spaulding Clinical Research LLC

Completed

Pharmacokinetics, Safety, and Tolerability of SYN-020

Enteritis Caused by Radiation (Disorder)

United States
Alnylam Pharmaceuticals

Completed

Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)

Elevated LDL-Cholesterol (LDL-C)

United Kingdom
Nottingham University Hospitals NHS Trust

Completed

Metformin Therapy in HCV Infection

Chronic Hepatitis C Infection

United Kingdom
Vedanta Biosciences, Inc.

Completed

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (CONSORTIUM)

Clostridium Difficile Infection | Clostridium Difficile Infection Recurrence | Clostridium Difficile | CDI | Clostridioides Difficile Infection | Clostridioides Difficile | Clostridioides Difficile Infection Recurrence

United States, Canada
Bristol-Myers Squibb

Terminated

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Crohn's Disease | Granulomatous Colitis | Crohn's Enteritis | Granulomatous Enteritis

Canada, Germany, Taiwan, United States, Spain, Australia, Poland, Russian Federation, Japan, Korea, Republic of, Romania, Italy, United Kingdom, Belgium, Brazil, China, Czechia, France, Hungary, Ireland, Israel, Mexico, Netherlands, P... and more
University Hospitals Coventry and Warwickshire...

Completed

Fibre-optic Guided Tracheal Intubation Through SADs

Airway Management | Intubation; Difficult or Failed | Laryngeal Masks

United Kingdom
University College London Hospitals

Completed

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

Chronic Hepatitis C, HCV Genotype 1

United Kingdom
University of Oxford

Completed

Understanding Immunity Persistence After Adolescent MenC Vaccination

Antibody Persistance After Booster Dose of Men C Vaccine

United Kingdom
Nottingham University Hospitals NHS Trust

Terminated

Ursodeoxycholic Acid in C. Difficile Infection

Clostridioides Difficile Infection

United Kingdom
Barts & The London NHS Trust

Unknown

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Clostridium Difficile Infection

United Kingdom
University of Nottingham
National Institute for Health Research, United Kingdom

Completed

Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea (RAPID)

Clostridium Difficile Infection

United Kingdom
University of Virginia
Imperial College London

Recruiting

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) (ACT)

Clostridium Difficile Infection | Clostridium Difficile Diarrhea | Clostridioides Difficile Infection | Clostridia Difficile Colitis

United States
University of Sussex
Danone Institute International

Completed

Probiotics in Preventing Antibiotic Associated Diarrhoea Including Clostridium Difficile Infection (NU278)

Diarrhoea | Clostridium Difficile

United Kingdom
University of Dundee

Active, not recruiting

Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV (ERAPID HCV)

Hepatitis C Viral

United Kingdom
Professor Mark Wilcox
The Leeds Teaching Hospitals NHS Trust; Astellas Pharma Europe Ltd.; St George...

Completed

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Clostridium Difficile Infection

United Kingdom
Arrow Therapeutics
DDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New Zealand

Terminated

A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers (CP104)

Chronic Hepatitis C

New Zealand, United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Use of Alexa as a Cognitive Aid for Emergency Front Of Neck Access (FONA) (FONA-A)

Intubation; Difficult or Failed

United Kingdom
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom
NHS Tayside

Completed

Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside

Hepatitis C, Chronic

United Kingdom
Bristol-Myers Squibb

Completed

Absolute Bioavailability of BMS-791325

Hepatitis C Virus Infection

United Kingdom
University of Arkansas

Withdrawn

UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Candidemia | Aspergillosis | C. Difficile

United States
University of Cambridge
Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Wellcome Trust and other collaborators

Active, not recruiting

PET Imaging of Giant Cell and Takayasu Arteritis (PITA)

Giant Cell Arteritis | Takayasu Arteritis

United Kingdom
Danone Research

Completed

A Single-centre, Randomised, Double-blind, Controlled, Parallel-group Study to Evaluate the Effect of a Fermented Dairy Product on Abdominal Distension, Digestive Symptoms and Rectal Sensitivity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Women With IBS-C

United Kingdom
King's College Hospital NHS Trust
Merck Sharp & Dohme LLC; Hepatitis C Trust

Terminated

ATTIC - Access To Treat in the Community (ATTIC)

Hepatitis C, Chronic

United Kingdom
Glasgow Royal Infirmary
Glasgow Caledonian University

Unknown

Re-engaging Patients With Hepatitis C Into Care

Hepatitis C, Chronic

United Kingdom

Clinical Trials on C. Difficile Enteritis in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations